BIOTRICITY, INC. (OTCMKTS:BTCY) Files An 8-K Regulation FD DisclosureItem 7.01
Regulation FD Disclosure
On April 23, 2018, Biotricity, Inc. (the “Company”) issued a press release announcing that the Company has achieved a commercial milestone with its first customer, the San Antonio Endovascular & Heart Institute.
A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 7.01 and in Item 9.01 of this report (including Exhibit 99.1) is being furnished to Item 7.01 and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the materiality of any information herein (including Exhibit 99.1).
Item 9.01 |
Financial Statements and Exhibits |
(d) Exhibits. The exhibit listed in the following Exhibit Index is furnished as part of this Current Report on Form 8-K:
Exhibit |
Description |
99.1 |
Press Release |
BIOTRICITY INC. ExhibitEX-99.1 2 f991.htm PRESS RELEASE Converted by EDGARwiz San Antonio Endovascular & Heart Institute First to Deploy Biotricitys New Bioflux Remote Monitoring Device Biotricity Achieves Commercial Milestone Ahead of Schedule with First Customer REDWOOD CITY,…To view the full exhibit click here
About BIOTRICITY, INC. (OTCMKTS:BTCY)
Biotricity Inc is a Canada-based medical technology company. The Company delivers remote biometric monitoring solutions, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. It offers bioflux, an Electrocardiogram (ECG) monitoring system that enables physicians to diagnose cardiovascular diseases or coronary heart diseases, acts as an ambulatory monitor that detects arrhythmias, performs remote mobile cardiac telemetry diagnostic monitoring, and transmits ECG data via a built-in cellular radio in real time. The Company also provides biolife, a health and lifestyle solution for individuals, which consists of a device that monitors heart-rhythm or ECG, as well as respiration, calories, temperature, physical activity, and other.